Free Trial
LON:GENF

Genflow Biosciences (GENF) Share Price, News & Analysis

GBX 0.90 -0.13 (-12.20%)
As of 05/2/2025 11:39 AM Eastern

About Genflow Biosciences Stock (LON:GENF)

Key Stats

Today's Range
0.85
1
50-Day Range
0.90
1.88
52-Week Range
0.85
3.41
Volume
6.34 million shs
Average Volume
2.08 million shs
Market Capitalization
£3.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

Receive GENF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GENF Stock News Headlines

Genflow Biosciences PLC (GENF)
See More Headlines

GENF Stock Analysis - Frequently Asked Questions

Genflow Biosciences' stock was trading at GBX 1.80 at the start of the year. Since then, GENF shares have decreased by 50.0% and is now trading at GBX 0.90.
View the best growth stocks for 2025 here
.

Genflow Biosciences plc (LON:GENF) issued its quarterly earnings data on Wednesday, April, 30th. The company reported ($0.47) earnings per share for the quarter. Genflow Biosciences had a negative trailing twelve-month return on equity of 208.12% and a net margin of 778.46%.

Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), Medical Properties Trust (MPW), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL).

Company Calendar

Last Earnings
4/30/2025
Today
5/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:GENF
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-1,760,791.46
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-226,187.99
Cash Flow
GBX 0.30 per share
Price / Cash Flow
3.00
Book Value
GBX 0.25 per share
Price / Book
3.63

Miscellaneous

Free Float
N/A
Market Cap
£3.07 million
Optionable
Not Optionable
Beta
2.37
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:GENF) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners